Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Other neoplasm 1

Conditions

Keratosis, Actinic 4Neoplasms 2Keratosis 2Stomach Neoplasms 1Precancerous Conditions 1Lymphoma 1Leukemia, Myeloid, Acute 1Carcinoma 1Breast Neoplasms 1Bone-Metastatic, Castration-Resistant Prostate Cancer 1

Interventions

Imiquimod 3tirbanibulin 2methyl 5-aminolevulinate 1Ointments 1BF-200 ALA 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Keratosis × tirbanibulin × Clear all
NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡